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Background: Prophylactic efficacy against colitis following lactobacillus consumption in interleukin 10
(IL-10) knockout (KO) mice has been reported. Whether this applies equally to other probiotic strains
is unknown, and the mechanism is unclear.
Aims: (1) To compare the effect of feeding Lactobacillus salivarius subspecies salivarius 433118 and
Bifidobacterium infantis 35624 against placebo on enterocolitis, the intestinal microflora, and (2) to
compare the systemic immunological response to in vitro microbial challenge in probiotic fed and con-
trol IL-10 KO mice.
Methods: Three groups of 10 IL-10 KO mice were fed fermented milk products containing Lb salivar-
ius 433118 at 109 CFU/ml, B infantis 35624 at 108 CFU/ml, and unmodified milk, respectively, for
19 weeks. Faecal samples were taken at regular intervals to confirm gut transit, recovery of fed probi-
otics, and to assess the impact on the microflora. At sacrifice, the bowels were histologically scored.
Cytokine production from Peyers’ patches and splenocytes was measured in vitro by ELISA.
Results: Faecal recovery of probiotics was confirmed in all probiotic fed mice but not in controls.
Colonic and caecal inflammatory scores were significantly decreased in both groups of probiotic fed
mice (p<0.05). Proinflammatory cytokine production by Peyers’ patches and splenocytes was signifi-
cantly reduced in probiotic fed animals whereas transforming growth factor β (TGF-β) levels were
maintained.
Conclusion: Both Lactobacillus salivarius 433118 and Bifidobacterium infantis 35624 significantly
attenuate colitis in this murine model. Attenuation of colitis is associated with a reduced ability to pro-
duce Th1-type cytokines systemically and mucosally, while levels of TGF-β are maintained.
The enteric microflora is implicated in driving theabnormal inflammatory response seen in individuals withinflammatory bowel disease.1 Certain murine models
develop spontaneous colitis similar to that of inflammatory
bowel disease. In these models, the influence of the enteric
flora on gut inflammatory activity has been demonstrated, as
germ free animals do not develop disease.2 3 One such murine
model is the interleukin 10 (IL-10) knockout (KO) mouse.4
Probiotic bacteria offer a means of modifying the enteric
microflora. Probiotics are live microorganisms that confer
health benefits through a number of mechanisms, such as
therapeutic modification of the enteric flora.5–7 We and others
have previously shown that consumption of probiotic lacto-
bacilli can attenuate colitis seen in IL-10 KO mice.8–11 It is not
known whether this effect also applies to other bacteria. In
addition, the probiotic mechanism of action is not well under-
stood. In our previous study, we demonstrated a significant
alteration in the microbial flora of probiotic fed mice, with a
reduction in Clostridia perfringens.8 Alteration in the enteric
flora is one possible explanation for the reduction seen in the
severity of gut inflammation. There is also evidence that com-
mensals signal to the gut epithelium and, in doing so, can
influence the mucosal immune response.9 10 The IL-10 KO
mouse is a useful model in which to further study a probiotic
effect on the immune response as intestinal inflammation is
associated with apparently dysregulated production of T
helper 1 (Th1)-type proinflammatory cytokines, similar to
that of Crohn’s disease.12–14 IL-12 and interferon γ (IFN-γ) are
key mediators responsible for inducing enterocolitis, with
IL-12 being necessary for sustaining the proliferation of
chronically activated Th1 cells.13
The purpose of the present study was: (i) to assess two dif-
ferent probiotic strains for their impact on colitis in IL-10 KO
mice; in particular, to investigate whether the beneficial effect
noted for lactobacilli in colitis is also seen with bifidobacteria.
In addition, (ii) we assessed the impact of probiotic bacteria
on cytokine production, both at the mucosal level and
systemically.
METHODS
IL-10 KO mice
Thirty 129 Ola×C57BL/6-IL10 KO female mice, aged 7–9 weeks
of age, were used in this study (B&K Universal Ltd, East York-
shire, UK). These mice were maintained on a homozygous
background and were housed under specific pathogen free
conditions. Mice were housed in a 12 hour light/dark cycle.
Following initiation of this study, all mice consumed a stand-
ard non-sterile diet. In our specific pathogen free animal
house, KO mice of this genetic background do not develop
colitis until>20 weeks. Thus this is a preventative study rather
than a treatment study.
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Probiotic strains
Lactobacillus salivarius subspecies salivarius UCC118 and Bifido-
bacterium infantis 35624 were originally isolated from the ileal-
caecal region of a human adult undergoing reconstructive
surgery. Both probiotic strains were isolated on the basis of
having desirable probiotic properties.7 15 16 Briefly, these prop-
erties included being of human origin, non- pathogenic,
resistant to intestinal acid and bile, ability to adhere to human
epithelial cells, and ability to temporarily colonise and to be
metabolically active within the human gastrointestinal tract.
Lb salivarius UCC118 was routinely cultured in de Man,
Rogosa, Sharpe (MRS) broth (Oxoid, UK) at 37°C in an
anaerobic environment for 24 hours. B infantis 35624 was cul-
tured in MRS broth (Oxoid) enriched with cysteine at 37°C in
an anaerobic environment for 48 hours. Spontaneous rif-
ampicin resistant variants of both strains were isolated, prior
to initiation of this study, in order to facilitate uncomplicated
identification of these bacteria from all other lactobacilli and
bifidobacteria.
Feeding trial
The 30 IL-10 KOmice were randomised to one of three groups.
The lactobacillus fed group consumed Lb salivarius subspecies
salivarius UCC118 at 1×109 organisms/ml of milk, the bifido-
bacterium fed group consumed B infantis 35624 at 1×108
organisms/ml of milk, while the control group consumed
unmodified pasteurised milk vehicle only. Mice were moni-
tored daily; each mouse consumed 4–7 ml of milk per day.
Mice in the lactobacillus fed group therefore consumed
4–7×109 organisms per day and mice in the bifidobacterium
fed group consumed 4–7×108 organisms per day. The probiotic
Lb salivarius UCC118 was initially grown to a 10 ml volume in
MRS broth (Oxoid) by incubating overnight at 37°C under
anaerobic conditions. A 1% inoculum (vol/vol) was transferred
to 400 ml of fresh MRS broth and incubated as before. Lb
Salivarius UCC118 was pelleted by centrifugation and resus-
pended at 1×109 cells/ml in 10% pasteurised skim milk.
B infantis 35624 was also grown to a 10 ml volume in MRS
broth enriched with 10% cysteine by incubating for 48 hours
at 37°C under anaerobic conditions. Again, a 1% inoculum
(vol/vol) was transferred to 400 ml of fresh MRS broth with
cysteine and incubated under the same conditions. B infantis
was pelleted by centrifugation and resuspended at 1×108
cells/ml in 10% pasteurised milk. Both probiotic containing
milk solutions and the unmodified pasteurised milk were
administered respectively to the groups of IL-10 KO mice in
water bottles and mice consumed the solutions ad libitum.
Murine faecal samples were collected at weekly intervals
over the trial period. The trial was completed after 19 weeks of
feeding, at which time all surviving mice were sacrificed by
cervical dislocation. The ileum, caecum, and colon were fixed
in formalin for histopathological analysis. Spleens were
removed from eachmouse at sacrifice and splenocytes isolated
for in vitro culturing.
Histopathology
At sacrifice, the ileum, caecum, proximal colon (ascending and
transverse colon), and distal colon (descending colon, rectum,
and anal canal) of all mice were fixed in 10% formalin and
assessed histologically. Two blinded independent observers,
using a histological index ranging from 0 to 4 as previously
published,8 graded the severity of inflammation at each site
within the murine gastrointestinal tract. This index was based
on the degree of epithelial layer erosion, goblet cell depletion,
and inflammatory cell infiltrate (0=normal; 1=minimal
evidence of inflammatory infiltrate; 2=significant evidence of
inflammatory infiltrate (cryptitis, crypt abscesses); 3=signifi-
cant evidence of inflammatory infiltrate with goblet cell
depletion; 4=significant evidence of inflammatory infiltrate
with erosion of the mucosa).
Microbial analysis
Faecal samples were collected weekly, weighed, and dispersed
in 10 ml of PBS. Microbial analysis of the faecal samples
involved enumeration of Lb salivarius subspecies salivarius
UCC118,B infantis 35624, total lactobacilli, total bifidobacteria,
coliforms, and C perfringens. This analysis was performed by
pour plating or spread plating onto MRS agar (pH 5.5) plus
rifampicin; MRS agar supplemented with 0.05% cysteine
hydrochloride (Sigma, St Louis, Missouri, USA) plus rif-
ampicin; MRS agar; MRS agar supplemented with 5% sheep
blood, 0.2% lithium chloride (BDH Laboratory Supplies, Poole,
UK), 0.3% sodium propionate (Sigma), and 0.05% cysteine
hydrochloride (Sigma); violet red bile agar (VRBA); and C per-
fringens selective medium OPSP with supplements A SR 76
and B SR 77, respectively (all Oxoid, UK, unless otherwise
stated). VRBA plates were incubated aerobically for 24 hours
while all other plates were incubated anaerobically for 48
hours at 37°C. Anaerobic environments were created using
CO2 generating kits (Anaerocult A; Merck, Damstadt, Ger-
many) in sealed gas jars (BBL Becton Dickinson, Cockeysville,
Maryland, USA).
DNA was extracted from faecal samples for microbial com-
munity profiling by denaturing gradient gel electrophoresis
(DGGE). DNA extraction from faecal cells was performed
using the BIO 101 FastDNA Spin kit for soil (BIO 101, Vista,
California, USA) according to the manufacturer’s instructions
with the following exceptions. The faecal pellet (10–30 mg)
was resuspended in 978 µl sodium phosphate buffer and 122
µl MT buffer from the BIO 101 kit. Bead beating of samples
was performed at 5000 rpm for 3×1 minute in a mini-bead
beater (Biospec Products, Bartlesville, Oklahoma, USA), with
a one minute chilling in ice between treatments. Following
bead beating, samples were centrifuged for four minutes;
100 µl of kit supplied DES buffer (DNA elution solution; ultra
pure water) was used to elute DNA from the matrix.
The total predominant bacterial community was profiled by
targeting the V6-V8 region of the 16S ribosomal DNA and
separating the resultant amplicons by DGGE using a gradient
of 38–48% (100% denaturing solution contains 7 M urea and
40% (v/v) formamide) as previously described.15 The Lactobacil-
lus population was profiled using nested polymerase chain
reaction (PCR) with Bact-0124-GCf and Univ-5125r primers
on previously generated products from amplification with
Bact-0011f and Lab-0677r.16 Bifidobacterium specific DGGE-
PCR was performed using Bif164-f and Bif662-GC-r primers,
as previously described.17 In an attempt to enhance the
DGGE-PCR detection sensitivity, the whole 16S rDNAwas first
amplified with primers Bact-0011f and 1492r,18 and the
resultant purified amplicons used as templates in a nested
PCR with species specific primers.
After electrophoresis, gels were silver stained.19 DGGE gels
were scanned at 400 dpi and profiles compared using the
Molecular Analyst 1.12 software (Biorad, Hemel Hempstead,
Hertfordshire, UK). Similarity indices were calculated from
densitometric curves of the scanned DGGE profiles using the
Pearson product moment correlation coefficient.20
Cytokine production by splenocytes
The spleens of all mice were removed at the time of sacrifice.
Each spleen was immediately placed in serum free DMEM.
The spleen was sieved through a sterilised metal filter into
5 ml of ammonium chloride, which lyses red blood cells. The
cell suspension was centrifuged twice at 100 g. Cells were
resuspended in DMEM (10% fetal calf serum) and diluted to
1×106 cells/ml for in vitro culturing. The isolated lymphocytes
were cocultured with the proinflammatory bacterium Salmon-
ella typhimurium (1×106 cells/ml) for 72 hours at 37°C. Cell
supernatants were isolated and stored at −80°C. Cytokine
analysis was performed on the supernatants using ELISA
(R&D, Abingdon, UK). Cytokines analysed were tumour
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necrosis factor α (TNF-α), IFN-γ, IL-12, and transforming
growth factor β (TGF-β).
Cytokine production by intestinal immunocytes (Peyers’
patches)
A subsequent separate group of IL-10 KO mice were analysed
for cytokine production by immunocytes at Peyers’ patches.
One group consumed B infantis 35624 at 1×108 organisms/ml
of milk while the control group consumed unmodified
pasteurised milk vehicle only (n=8 per group). The small
intestines of the mice were removed by dissection and the
lymphoid follicles of the Peyers’ patches carefully removed
from the intestinal serosal side with curved scissors. Seven to
10 Peyers’ patches were obtained per mouse, collected in 5 ml
of phosphate buffered saline containing 1 mM EDTA and
1 mM collagenase (Sigma; C-6885, type II) and placed in a
shaking oven at 37°C for 20 minutes. The collected patches
were then placed between two sterile glass slides and
smashed. Immunocytes from the follicles were released into
the medium. This cell suspension was centrifuged (100 g×10
minutes) and the pellet was resuspended and diluted in
DMEM, 25 mM glucose supplemented with 1% penicillin-
streptomycin, and 40 µg/ml gentamicin (Faulding Pharma-
ceuticals Plc, UK) to a concentration of 106 cells/ml.
Peyers’ patches cells were seeded under duplicate condi-
tions in 24 well tissue culture plates (Costar, Corning, New
York, USA) at 1×106 cells per well. Following a 72 hour incuba-
tion period (5% CO2 and 37°C humidified atmosphere) all
supernatants were harvested for analysis of TNF-α and IFN-γ
cytokines. Cytokine production was measured by ELISA (R&D
Systems, Abingdon, UK and BD, Pharmingen, Oxford, UK).
Statistical analysis
Analysis of variance for differences between groups in inflam-
matory activity was carried out using ANOVA while differ-
ences between groups in microbial numbers were estimated
using area under the curve analysis. A value of p<0.05 was
considered to be statistically significant.
RESULTS
Histopathology
Post sacrifice, a score of 0–4 was awarded to each examined
area of bowel: caecum, proximal colon (ascending and trans-
verse colon), and distal colon (descending colon, rectum, and
anal canal) with a total possible score of 12 awarded to each
Figure 1 Gastrointestinal inflammatory score, including the ileum,
caecum, and colon, in probiotic and control fed groups (*p<0.05;
n=10 each group). Results are expressed as mean (SEM)
inflammatory score.
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Figure 2 Recovery of Bifidobacteria infantis 35624 (A) and Lactobacillus salivarius 118 (B) in stool from probiotic fed mice. Results are
expressed as mean (SEM) colony forming units/g (CFU/g). No probiotics were isolated from mice in the placebo group.
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Figure 3 Culture independent molecular profile (16s rDNA DGGE) of faecal flora from control fed mice and probiotic fed mice (A). Lane M,
molecular marker; lanes 5.1–5.6, control fed mice; lanes 6.1–6.6, Lactobacillus salivarius subspecies salivarius UCC118 fed mice; Lane Lb,
pure culture of Lb salivarius UCC118. The accompanying dendrogram (B) shows similarity indices for the dominant flora, as assessed by image
analysis of the gel. The banding profiles for the two groups of mice are distinct and cluster separately.
                  	


 
	 

  !"

  #$% &'
  #$% &'
  #$% &'
  #$% &'
  #$% &'

 &'

 &'
  #$% &'

 &'

 &'

 &'

 &'
Probiotic strains in IL-10 KO mice and link with cytokine balance 977
www.gutjnl.com
 group.bmj.com on December 27, 2011 - Published by gut.bmj.comDownloaded from 
mouse gut. When all sections had been examined, the mean
score for each group was calculated.Mean inflammatory score
for the control group was 8.25 (SEM 0.94). Mean inflamma-
tory scores for the Lb salivarius group and the B infantis groups
were 5.25 (0.5) and 4.6 (0.6), respectively. Both probiotic fed
groups showed a significant reduction compared with the
control group (p<0.05) (fig 1). In addition, four mice in the
control group were found to have pancolitis, with the entire
proximal and distal colon equally affected. No cases of
pancolitis were seen in either of the probiotic fed groups.
Microbial analysis
Faecal samples from all mice were analysed to assess transit of
the probiotic strains. The probiotic strains were recovered in
faeces from all mice in both test groups, within one week of
feeding, confirming survival and transit of both the probiotics
in the test mice. Lb salivarius UCC118 was recovered in stool
samples at 1×108 colony forming units/g (CFU/g) byweek 15 of
feeding. Stool recovery of B infantis 35624 was approximately
1×105 CFU/g by week 12 of feeding (fig 2). The probiotic
strains were not isolated from any of the mice in the placebo
group.
There was no significant difference in culturable bacteria
when total lactobacilli, total bifidobacteria, coliforms, and
C perfringenswere counted in faecal samples, unlike in the pre-
vious trial.8 However, comparison of culture independent
molecular profiles (16s rDNA DGGE) of faecal flora from con-
trol fed mice and probiotic fed mice indicated differences in
the dominant microflora of the groups (fig 3A). Each mouse
had a distinct individual profile for the dominant microbiota,
although there were bands in common. The profiles within
each study group were more similar than when compared
across groups. The accompanying dendrogram (fig 3B) shows
similarity indices for the dominant flora, as assessed by image
analysis of the gel. The banding profiles of the control mice
clustered together in the dendrogram and were distinct from
the profiles generated from the Lactobacillus fed mice. Thus
ingestion of Lb salivarius UCC118 influenced the dominant
microbiota of the mice. Similarly, the dominant microflora
profiles seen in Bifidobacterium fed mice differed from control
mice, but lactobacillus and bifidobacterium specific profiles
were not altered significantly (data not shown).
Cytokine production
Splenocytes
Cytokine analysis was performed on splenocyte supernatants
by ELISA following stimulation in vitro with the proinflam-
matory bacterium S typhimurium. The proinflammatory
cytokines IFN-γ, TNF-α, and IL-12 were significantly reduced
in the group fed B infantis 35624. In contrast, production of the
anti-inflammatory cytokine TGF-β was maintained in all
groups (fig 4). Changes in proinflammatory cytokine produc-
tion were greater in the bifidobacterium fed group than in the
lactobacillus fed group, and this reached significance in the
case of IFN-γ. Resting levels of IL-12 in splenocyte superna-
tants were reduced in both probiotic fed groups compared
Figure 4 Cytokine production by stimulated splenocytes in placebo fed and probiotic fed mice. Results are expressed as mean (SEM)
cytokine levels per group. There was a significant reduction in the proinflammatory cytokines (interferon γ (IFN) (A), tumour necrosis factor α
(TNF) (C), and interleukin 12 (IL-12) (B)) with maintenance of the anti- inflammatory transforming growth factor β (TGF) (D) (*p<0.05; n=10).
Resting levels of TNF-α, IFN-γ, and TGF-β were not detectable in non-stimulated cultures. Resting IL-12 levels were lower in both probiotic fed
groups compared with the control group but did not reach statistical significance.
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Figure 5 Resting in vitro production of tumour necrosis factor α
(TNF) and interferon γ (IFN) by intestinal mononuclear cells from
Peyers’ patches in placebo fed and probiotic fed mice
(Bifidobacterium infantis 35624). Results are expressed as mean
(SEM) cytokine levels per group (*p<0.05; n=8).
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with the control group but did not reach statistical signifi-
cance. TNF-α, IFN-γ, and TGF-β levels were not detectable in
non-stimulated cultures.
Intestinal immunocytes (Peyers’ patches)
Cytokine analysis was performed on supernatants of Peyers’
patches cells in a separate group fed B infantis 35624 and con-
temporaneous controls. Spontaneous production of TNF-α
and IFN-γ was significantly reduced in animals fed B infantis
35624 compared with controls (fig 5).
DISCUSSION
The probiotics used in this study (Lactobacillus salivarius
subspecies salivarius UCC118 and Bifidobacterium infantis
35624) are well characterised and have been demonstrated to
be bile tolerant and acid resistant, and to survive passage
through the gastrointestinal tract.21 22 They are non-
pathogenic and have been tested in human trials of healthy
volunteers and patients with Crohn’s disease7 (unpublished).
The results of the present study confirm survival of both pro-
biotics following murine gastrointestinal transit and show
that both strains attenuate colitis in the IL-10 KO model. The
probiotic effect on mucosal inflammation was reflected in a
reduction in the proinflammatory cytokines TNF-α and IFN-γ,
secreted by intestinal Peyers’ patches cells. This attenuation of
colitis is consistent with our previous study involving the
lactobacillus strain8 and is the first report of a beneficial effect
using bifidobacteria in this model. The beneficial probiotic
impact on mucosa was also associated with changes in
systemic cytokine production in vitro. Following challenge (in
vitro with S typhimurium), there was a reduction in Th1 cyto-
kines (TNF-α, IFN-γ, and IL-12) in the probiotic groups
whereas production of the immunoregulatory (Th3) cytokine
TGF-β was maintained.
Probiotic consumption also altered the culture independent
molecular profiles of the predominant microflora in the
murine gastrointestinal tract. Although there were no detect-
able differences in the culturable bacteria examined, differ-
ences in the DGGE banding profiles representing the
dominant microflora in the three groups indicated changes in
unidentified bacterial groups in the probiotic fed animals.
A variety of mechanisms may be responsible for the
observed probiotic attenuation of colitis. The effects of
probiotic consumption on host immune function have
previously been discussed.23–25 Attenuation of colitis in the
IL-10 KO model suggests that mediators other than IL-10 are
involved in the demonstrable probiotic efficacy. Alteration in
cytokine profiles observed is important as inflammation in
both Crohn’s disease and this murine model is associated with
a predominance of Th1 cytokines, whereas Th3 cells, produc-
ing TGF-β, are involved in suppressing inflammatory re-
sponses and promoting tolerance.10 26–28 The results suggest
that the probiotic effect may be mediated by altering the bal-
ance between proinflammatory and anti-inflammatory or
regulatory cytokines. Secretion of cytokines by isolated
splenocytes in vitro is dependent on the stimulus used and the
cytokine milieu the cells were isolated from. In this study, the
stimulus used was identical in each group. This suggests that
it is the cytokine environments from which these cells were
isolated which differ.
S typhimurium was chosen as the in vitro challenge because
it is a reliable and relevant biological stimulus, being a Gram
negative bacteria containing lipopolysaccharide endotoxin.
The probiotic linked reduction of inflammatory cytokines in
response to the in vitro challenge does not however imply that
these mice are more susceptible to infection with this patho-
gen. Using the same probiotic organisms, we have shown a
benefit in mice infected with the salmonella organism with
significantly reduced pathogen survival and translocation in
mice fed probiotics (O’Mahony et al, in press).
Even though there was no difference in the histological
score between the two probiotic groups, it is noteworthy that
there was a strong trend towards lower levels of the systemic
Th1 cytokines in the bifidobacteria group compared with the
lactobacilli group. However, this only reached statistical
significance in the case of IFN-γ. Whether this reflects a more
potent anti-inflammatory effect is unknown at this stage. The
effect may not be proportional to the dose of organism but
related to variations in mechanism.
Probiotic bacteria are attractive alternatives for the treat-
ment of gastrointestinal inflammation due to their effects on
the composition of the gut flora and activity of the immune
system.29 Administration of the probiotic organisms in this
study attenuated inflammation and altered the systemic
immune response of IL-10 KO mice. The probiotic effect is
modest but is consistent and not limited to lactobacilli. How-
ever, results cannot be extrapolated to all lactobacilli or bifido-
bacteria strains. Further study of the therapeutic role of these
probiotic bacteria in human trials is warranted. It is tempting
to suggest that a combination of probiotics would be synergis-
tic but this cannot be assumed; some combinations may even
be antagonistic.30 Probiotic cocktails should therefore be care-
fully studied and the individual bacterial constituents
evaluated before routine use in clinical settings. Several stud-
ies are currently underway to assess these issues, including an
EU funded, multicentre, placebo controlled trial testing both
Lb salivarius and B infantis in the setting of Crohn’s disease and
ulcerative colitis.
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